The FTSE 100 hit another record high on Wednesday, despite concerns over the US shutdown, as pharmaceutical stocks powered ...
Conagra Brands Inc. (NYSE:CAG) on Wednesday posted first-quarter fiscal 2026 results that topped Wall Street expectations but ...
The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new ...
Wall Street opened lower on Wednesday, while the FTSE 100 (^FTSE) and European stocks advanced, as a report showed US private ...
NUBURU, Inc. (NYSE American: BURU), a global leader in high-performance blue laser technology, announced the implementation of a dual-CEO structure, effective October 1, 2025. This strategic ...
BROS' Rewards engine, powering 72% of Q2 transactions, is driving order ahead gains, food pilots and deeper customer ...
GSK plc (LSE/NYSE: GSK) today announced a major update to Vaccine Track, a first-of-its-kind, interactive public data tool for tracking adult immunization activity in the US. Users can now explore ...
Jon Edwards, PhD, joins Forbion as PartnerBased in Boston, Edwards will help drive new investments and support portfolio ...
Here are three stocks with buy rank and strong income characteristics for investors to consider today, October 1st: Aviva ...
FDA to review AEON’s analytical development plan and initial data - IRVINE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a biopharmaceutical ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the first patient has been dosed in ZENITH (ZilebEsiraN CardIovascular OuTcome Study in ...
GENEVA (Reuters) -Swiss pharma companies are likely to follow Pfizer's price deal with the U.S. following a demand from ...